全文获取类型
收费全文 | 5209篇 |
免费 | 280篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 96篇 |
儿科学 | 274篇 |
妇产科学 | 43篇 |
基础医学 | 563篇 |
口腔科学 | 127篇 |
临床医学 | 354篇 |
内科学 | 1178篇 |
皮肤病学 | 187篇 |
神经病学 | 272篇 |
特种医学 | 80篇 |
外科学 | 880篇 |
综合类 | 118篇 |
一般理论 | 1篇 |
预防医学 | 226篇 |
眼科学 | 188篇 |
药学 | 414篇 |
中国医学 | 18篇 |
肿瘤学 | 493篇 |
出版年
2024年 | 3篇 |
2023年 | 28篇 |
2022年 | 64篇 |
2021年 | 198篇 |
2020年 | 102篇 |
2019年 | 143篇 |
2018年 | 189篇 |
2017年 | 122篇 |
2016年 | 162篇 |
2015年 | 178篇 |
2014年 | 254篇 |
2013年 | 312篇 |
2012年 | 497篇 |
2011年 | 505篇 |
2010年 | 283篇 |
2009年 | 225篇 |
2008年 | 359篇 |
2007年 | 337篇 |
2006年 | 323篇 |
2005年 | 295篇 |
2004年 | 257篇 |
2003年 | 243篇 |
2002年 | 205篇 |
2001年 | 26篇 |
2000年 | 24篇 |
1999年 | 32篇 |
1998年 | 27篇 |
1997年 | 21篇 |
1996年 | 19篇 |
1995年 | 6篇 |
1994年 | 9篇 |
1993年 | 8篇 |
1992年 | 4篇 |
1991年 | 4篇 |
1990年 | 4篇 |
1989年 | 8篇 |
1988年 | 7篇 |
1987年 | 3篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1982年 | 3篇 |
1981年 | 3篇 |
1979年 | 2篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1973年 | 4篇 |
1972年 | 1篇 |
1970年 | 1篇 |
1954年 | 1篇 |
1949年 | 1篇 |
排序方式: 共有5512条查询结果,搜索用时 62 毫秒
61.
62.
63.
Sunil Kumar Garg 《Indian Journal of Critical Care Medicine》2015,19(4):227-229
Bodybuilding is the use of progressive resistance exercise to control and develop one''s musculature. With the rise in number of persons adopting this activity, there is evolving paradigm of illnesses presented to intensive care in this population subset. Strict adherence to details of bodybuilding and avoidance of unsupervised medications are essential to prevent untoward effects. 相似文献
64.
Martial L. Ndeffo Mbah Sunil Parikh Alison P. Galvani 《The American journal of tropical medicine and hygiene》2015,92(3):555-560
Artemisinin-based combination therapies (ACTs) are currently considered the first-line treatments for uncomplicated Plasmodium falciparum malaria. Among these, artemether-lumefantrine (AL) has been the most widely prescribed ACT in sub-Saharan Africa. Recent clinical trials conducted in sub-Saharan Africa have shown that dihydroartemisinin-piperaquine (DP), a most recent ACT, may have a longer post-treatment prophylactic period and post-treatment infection period (duration of gametocyte carriage) than AL. Using epidemiological and clinical data on the efficacy of AL and DP, we developed and parameterized a mathematical transmission model that we used to compare the population-level impact of AL and DP for reducing P. falciparum malaria transmission in sub-Saharan Africa. Our results showed that DP is likely to more effectively reduce malaria incidence of clinical episodes than AL. However in low P. falciparum transmission areas, DP and AL are likely to be equally effective in reducing malaria prevalence. The predictions of our model were shown to be robust to the empirical uncertainty summarizing the epidemiological parameters. DP should be considered as a replacement for AL as first-line treatment of uncomplicated malaria in highly endemic P. falciparum communities. To optimize the effectiveness of ACTs, it is necessary to tailor treatment policies to the transmission intensity in different settings. 相似文献
65.
66.
Male breast cancer (MBC) is an uncommon and poorly understood disease. Recent molecular studies have shown important differences from female breast cancer which are likely to influence treatment strategies from the current female‐based management towards a more tailored approach. Significantly more MBCs than female breast cancers arise with an underlying germline cancer predisposition, and display a vastly different penetrance compared with females. Furthermore, the genophenotypical association of basal‐like cancer with BRCA1 present in female breast cancer is not observed in male breast cancer. Differences in somatic changes between male and female breast cancer have also been reported, with particular enrichment of PIK3CA mutations and a paucity of TP53 mutations. In general, chromosomal‐based changes, in particular regions of gains, are seen more frequently in male than female breast cancer and methylation is seen less frequently. Clinically, several molecular subtypes with prognostic relevance have been described, including chromosomal complex high and methylation high groups, and subgroups with profiling signatures pertaining to epithelial mesenchymal transition and hormonal therapy insensitivity. As with female breast cancer, attention to male specific multicentre trials based on the individual characteristics are needed, together with establishment of reliable preclinical models to understand more clearly the pathogenesis of male breast cancer and improve the general poor outcome of this disease. 相似文献
67.
68.
69.
70.